Atlas Trials

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Clinical trial NCT00157872 · COMPLETED

Trial details

NCT number
NCT00157872
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2004-01-07
Primary completion
2004-07-05
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.